4,312 Shares in MetLife, Inc. (NYSE:MET) Bought by Scissortail Wealth Management LLC

Scissortail Wealth Management LLC purchased a new position in shares of MetLife, Inc. (NYSE:METFree Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 4,312 shares of the financial services provider’s stock, valued at approximately $303,000.

A number of other large investors have also recently bought and sold shares of MET. International Assets Investment Management LLC raised its position in MetLife by 678.4% during the 4th quarter. International Assets Investment Management LLC now owns 287,311 shares of the financial services provider’s stock worth $19,000,000 after buying an additional 250,402 shares during the last quarter. AustralianSuper Pty Ltd increased its holdings in shares of MetLife by 19.2% in the 4th quarter. AustralianSuper Pty Ltd now owns 1,824,596 shares of the financial services provider’s stock valued at $120,661,000 after purchasing an additional 293,925 shares in the last quarter. Nordea Investment Management AB increased its holdings in shares of MetLife by 9.9% in the 4th quarter. Nordea Investment Management AB now owns 2,664,012 shares of the financial services provider’s stock valued at $176,304,000 after purchasing an additional 240,564 shares in the last quarter. Acadian Asset Management LLC increased its holdings in shares of MetLife by 50.0% in the 3rd quarter. Acadian Asset Management LLC now owns 8,856 shares of the financial services provider’s stock valued at $557,000 after purchasing an additional 2,952 shares in the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH increased its holdings in shares of MetLife by 13.1% in the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 742,302 shares of the financial services provider’s stock valued at $49,088,000 after purchasing an additional 86,091 shares in the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

Insider Activity at MetLife

In related news, EVP Bill Pappas sold 27,000 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total value of $1,951,290.00. Following the transaction, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the sale, the executive vice president now owns 57,768 shares in the company, valued at $4,174,893.36. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the sale, the insider now owns 146,981 shares in the company, valued at $10,567,933.90. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

MetLife Trading Down 0.7 %

Shares of MET traded down $0.51 during mid-day trading on Wednesday, hitting $68.93. The company had a trading volume of 3,330,324 shares, compared to its average volume of 2,511,324. The business’s 50-day simple moving average is $70.95 and its 200-day simple moving average is $66.66. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.53. MetLife, Inc. has a 1-year low of $48.95 and a 1-year high of $74.68. The stock has a market cap of $49.84 billion, a PE ratio of 37.67, a P/E/G ratio of 0.52 and a beta of 1.04.

MetLife (NYSE:METGet Free Report) last released its earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a return on equity of 19.48% and a net margin of 2.36%. The company had revenue of $18.72 billion during the quarter, compared to analyst estimates of $18.07 billion. Sell-side analysts forecast that MetLife, Inc. will post 8.71 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on MET shares. Morgan Stanley increased their price target on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a report on Monday. Keefe, Bruyette & Woods increased their price target on shares of MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a report on Wednesday, April 10th. Wells Fargo & Company increased their price objective on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. The Goldman Sachs Group raised shares of MetLife from a “neutral” rating to a “buy” rating and increased their price objective for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Finally, Piper Sandler increased their price objective on shares of MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Two research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.23.

View Our Latest Stock Analysis on MET

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

See Also

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:METFree Report).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.